In May 2023, we attended IMMUNOLOGY2023, the annual meeting of the American Association of Immunologists in Washington, DC, and recorded daily episodes discussing highlights of the previous 24 hours. Here is the second of five special episodes from the meeting. Brenda and Jason discuss sessions on peripheral neuroimmune interactions and tumor cellular therapy. Highlights include the President’s Address by Dr. Mark Davis and Dr. Barbara Rehermann’s presentation on wild mouse microbiota.

IMMUNOLOGY2023: Day 2
The Immunology Podcast
00:00
Car Encasals Target a CD70 Positive O-CZR Coma
There was an interesting talk from Emily Simun-Rav from the University of Texas MD Anderson Center in which they are using car encasals to target a CD70 positive O-CZR coma. And also it was interesting for me because I don't know, I don't work a lot of it in case cells, but, and this is probably one of the limitations of NCIR therapy is that they seem to have limited persistence,. More limited than T cells. So how do you accept that or how do you work around that limitation? That's a very busy day. Yeah, so then there's the IL-1, IL-6 inhibitors, which are used for cytok
Transcript
Play full episode